About

How We do

  • 01. Seed Discovery & Early-Stage Investment
    Discover technology seeds through long-term collaboration with industry, universities, institutes, and hospitals
    Technology incubation through in-house translational research
  • 02. Concentration
    Focus on selected companies, specific fields
    Long-term human and material support (from start-up to success)
    Function as a launchpad for entry into the US market
  • 03. Ecological Approach
    Develop joint businesses and startups considering technological and business connectivity within the ecosystem
    Provide a variety of financial options for establishing a virtuous cycle of funds within the ecosystem
    (Angel investment, Investor connection, M&A, Loan, Out-licensing, etc.)

Approach

  • Let Them Start
    We serve as a midwife for technology startups, bringing together technology, people, funding, and infrastructure to commercialize them. This provides an environment in which many potential entrepreneurs can take on more challenging ventures based on their skills, allowing many technologies that began in the lab to access the market.
  • Let Them Survive
    We provide capital and infrastructure to promising biotech ventures until they can adjust to the challenging business environment, establish themselves in the market, and flourish independently. Given the nature of biotechnology, biotech ventures require a lengthy technology development phase as well as substantial financial support. Due to large uncertainties, they also show a lower survival rate than other technology-based ventures. Beyond providing space and investment funds, we jointly carry out biotech ventures while providing tangible and intangible assets necessary for business development.
  • Let Them Succeed
    We function as a launchpad for self-sustaining biotech ventures to enter and succeed in the global market, particularly in the United States. Clinical validation in the United States is required for the long-term growth of biotech ventures. By creating a bridgehead in the US market, we lower the risks of individual biotech ventures and help secure competitiveness in the early stages.

Focus Areas

Bio & Healthcare Technology

  • Therapeutics Anti-cancer drugs (chemical, antibody, ADC) / Cell Therapy
  • Diagnotics Early cancer detection / Cancer monitoring / NIPT / Liquid biopsy (cfDNA, CTCs, Exosomes)
  • Regenerative medicine Personalized 3D printing
  • Online healthcare Patient community channel
  • AI-based technology Imaging analytics / Digital science

Partners

We collaborate with companies, universities, research institutes, and hospitals to establish biotech ventures and build business ecosystems.